BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 33530355)

  • 1. One Year of SARS-CoV-2: How Much Has the Virus Changed?
    Vilar S; Isom DG
    Biology (Basel); 2021 Jan; 10(2):. PubMed ID: 33530355
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Geographical distribution of SARS-CoV-2 amino acids mutations and the concomitant evolution of seven distinct clades in non-human hosts.
    Magateshvaren Saras MA; Patro LPP; Uttamrao PP; Rathinavelan T
    Zoonoses Public Health; 2022 Nov; 69(7):816-825. PubMed ID: 35614572
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Global variation in SARS-CoV-2 proteome and its implication in pre-lockdown emergence and dissemination of 5 dominant SARS-CoV-2 clades.
    Patro LPP; Sathyaseelan C; Uttamrao PP; Rathinavelan T
    Infect Genet Evol; 2021 Sep; 93():104973. PubMed ID: 34147651
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evolution of SARS-CoV-2 Envelope, Membrane, Nucleocapsid, and Spike Structural Proteins from the Beginning of the Pandemic to September 2020: A Global and Regional Approach by Epidemiological Week.
    Troyano-Hernáez P; Reinosa R; Holguín Á
    Viruses; 2021 Feb; 13(2):. PubMed ID: 33557213
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of intercontinents mutation hotspots and conserved domains within SARS-CoV-2 genome.
    Omotoso OE; Olugbami JO; Gbadegesin MA
    Infect Genet Evol; 2021 Dec; 96():105097. PubMed ID: 34606987
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The extent of molecular variation in novel SARS-CoV-2 after the six-month global spread.
    Bui NN; Lin YT; Huang SH; Lin CW
    Infect Genet Evol; 2021 Jul; 91():104800. PubMed ID: 33677109
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Haplotype distribution of SARS-CoV-2 variants in low and high vaccination rate countries during ongoing global COVID-19 pandemic in early 2021.
    Bui NN; Lin YT; Huang SH; Lin CW
    Infect Genet Evol; 2022 Jan; 97():105164. PubMed ID: 34848355
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular Epidemiology Surveillance of SARS-CoV-2: Mutations and Genetic Diversity One Year after Emerging.
    Flores-Alanis A; Cruz-Rangel A; Rodríguez-Gómez F; González J; Torres-Guerrero CA; Delgado G; Cravioto A; Morales-Espinosa R
    Pathogens; 2021 Feb; 10(2):. PubMed ID: 33572190
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlates of SARS-CoV-2 Variants on Deaths, Case Incidence and Case Fatality Ratio among the Continents for the Period of 1 December 2020 to 15 March 2021.
    J Al-Awaida W; Jawabrah Al Hourani B; Swedan S; Nimer R; Alzoughool F; J Al-Ameer H; E Al Tamam S; Alashqar R; Al Bawareed O; Gushchina Y; Samy Abousenna M; Ayyash AM; Sharab A; M Alnaimat S; Imraish A; W Akash M; R Hadi N
    Genes (Basel); 2021 Jul; 12(7):. PubMed ID: 34356077
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phylogenetic and genome-wide mutational analysis of SARS-CoV-2 strains circulating in Nigeria: no implications for attenuated COVID-19 outcomes.
    Kolawole DB; Okeke MI
    Osong Public Health Res Perspect; 2022 Apr; 13(2):101-113. PubMed ID: 35538682
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutations of SARS-CoV-2 Structural Proteins in the Alpha, Beta, Gamma, and Delta Variants: Bioinformatics Analysis.
    Khetran SR; Mustafa R
    JMIR Bioinform Biotech; 2023; 4():e43906. PubMed ID: 37485046
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prediction of the effects of the top 10 nonsynonymous variants from 30229 SARS-CoV-2 strains on their proteins.
    Sia BZ; Boon WX; Yap YY; Kumar S; Ng CH
    F1000Res; 2022; 11():9. PubMed ID: 35707000
    [No Abstract]   [Full Text] [Related]  

  • 13. Mutations in SARS-CoV-2 structural proteins: a global analysis.
    Abavisani M; Rahimian K; Mahdavi B; Tokhanbigli S; Mollapour Siasakht M; Farhadi A; Kodori M; Mahmanzar M; Meshkat Z
    Virol J; 2022 Dec; 19(1):220. PubMed ID: 36528612
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The British variant of the new coronavirus-19 (Sars-Cov-2) should not create a vaccine problem.
    Conti P; Caraffa A; Gallenga CE; Kritas SK; Frydas I; Younes A; Di Emidio P; Tetè G; Pregliasco F; Ronconi G
    J Biol Regul Homeost Agents; 2021; 35(1):1-4. PubMed ID: 33377359
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evolutionary Tracking of SARS-CoV-2 Genetic Variants Highlights an Intricate Balance of Stabilizing and Destabilizing Mutations.
    Jacob JJ; Vasudevan K; Pragasam AK; Gunasekaran K; Veeraraghavan B; Mutreja A
    mBio; 2021 Aug; 12(4):e0118821. PubMed ID: 34281387
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of lockdown on Covid-19 case fatality rate and viral mutations spread in 7 countries in Europe and North America.
    Pachetti M; Marini B; Giudici F; Benedetti F; Angeletti S; Ciccozzi M; Masciovecchio C; Ippodrino R; Zella D
    J Transl Med; 2020 Sep; 18(1):338. PubMed ID: 32878627
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Spike protein D614G and RdRp P323L: the SARS-CoV-2 mutations associated with severity of COVID-19.
    Biswas SK; Mudi SR
    Genomics Inform; 2020 Dec; 18(4):e44. PubMed ID: 33412760
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Novel Coronavirus Enigma: Phylogeny and Analyses of Coevolving Mutations Among the SARS-CoV-2 Viruses Circulating in India.
    Banerjee A; Sarkar R; Mitra S; Lo M; Dutta S; Chawla-Sarkar M
    JMIR Bioinform Biotech; 2020; 1(1):e20735. PubMed ID: 33496683
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic diversity and genomic epidemiology of SARS-CoV-2 in Morocco.
    Badaoui B; Sadki K; Talbi C; Salah D; Tazi L
    Biosaf Health; 2021 Apr; 3(2):124-127. PubMed ID: 33558859
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SARS-CoV-2: analysis of the effects of mutations in non-structural proteins.
    Senthilazhagan K; Sakthimani S; Kallanja D; Venkataraman S
    Arch Virol; 2023 Jun; 168(7):186. PubMed ID: 37344726
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.